Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion
OTCMKTS:CLABD

Core One Labs (CLABD) Stock Price, News & Analysis

Core One Labs logo

About Core One Labs Stock (OTCMKTS:CLABD)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
48,295 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Core One Labs Inc. is a Canadian life sciences company focused on the development of psychedelic-based pharmaceutical products and related drug-delivery technologies. Its stated objective has been to support the development of treatments derived from compounds such as psilocybin and other psychedelics for potential use in mental-health and neurological applications.

The company has also pursued research, formulation and commercialization initiatives through subsidiaries and strategic relationships, including work involving psychedelic-assisted therapies. Historically, Core One Labs has been involved in cannabis-related biotechnology and biosynthesis research, although its public corporate focus has increasingly emphasized psychedelic medicine and pharmaceutical development.

Core One Labs has been headquartered in Canada and has described its activities as serving the emerging international psychedelic-medicine and biotechnology markets. Publicly available information does not provide sufficient current detail to reliably summarize its leadership structure or the full geographic scope of its operations.

AI Generated. May Contain Errors.

Receive CLABD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLABD Stock News Headlines

Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations.tc pixel
Stifel Nicolaus Sticks to Their Hold Rating for Core Laboratories (CLB)
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:CLABD
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (OTCMKTS:CLABD) was last updated on 10/28/2026 by MarketBeat.com Staff.
From Our Partners